Market Cap ₹412 Cr.
Stock P/E 0.0
P/B 4.2
Current Price ₹233.5
Book Value ₹ 55.4
Face Value 10
52W High ₹293.5
Dividend Yield 0%
52W Low ₹ 146
Saakshi Medtech & Panels Ltd is a pioneering company at the intersection of medical technology and advanced panel solutions. With a commitment to innovation and precision, they specialize in the development and production of cutting-edge medical devices and high-quality panels for various industries. In the medical field, Saakshi Medtech & Panels Ltd designs and manufactures state-of-the-art medical equipment, such as diagnostic devices, patient monitoring systems, and surgical instruments, contributing to improved healthcare outcomes and patient well-being. Simultaneously, their expertise extends to producing premium panels used in sectors like aerospace, automotive, and electronics, ensuring reliability and efficiency in critical applications. The company's dedication to research, development, and quality makes them a trusted partner for innovation and technology across diverse industries.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) |
|---|
| Net Sales |
| Other Income |
| Total Income |
| Total Expenditure |
| Operating Profit |
| Interest |
| Depreciation |
| Exceptional Income / Expenses |
| Profit Before Tax |
| Provision for Tax |
| Profit After Tax |
| Adjustments |
| Profit After Adjustments |
| Adjusted Earnings Per Share |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
|---|---|---|---|---|---|
| Net Sales | 61 | 60 | 92 | 122 | |
| Other Income | 0 | 0 | 0 | 0 | |
| Total Income | 62 | 60 | 92 | 122 | |
| Total Expenditure | 50 | 54 | 76 | 102 | |
| Operating Profit | 12 | 6 | 16 | 21 | |
| Interest | 2 | 1 | 1 | 1 | |
| Depreciation | 2 | 2 | 2 | 3 | |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | |
| Profit Before Tax | 8 | 3 | 13 | 17 | |
| Provision for Tax | 2 | 1 | 3 | 4 | |
| Profit After Tax | 6 | 2 | 9 | 12 | |
| Adjustments | 0 | 0 | 0 | 0 | |
| Profit After Adjustments | 6 | 2 | 9 | 12 | |
| Adjusted Earnings Per Share | 4.5 | 1.6 | 7.2 | 9.5 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 33% | 26% | 0% | 0% |
| Operating Profit CAGR | 31% | 21% | 0% | 0% |
| PAT CAGR | 33% | 26% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | NA% | NA% | NA% | NA% |
| ROE Average | 34% | 28% | 29% | 29% |
| ROCE Average | 33% | 26% | 26% | 26% |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|
| Shareholder's Funds | 18 | 20 | 30 | 42 |
| Minority's Interest | 0 | 0 | 0 | 0 |
| Borrowings | 8 | 8 | 7 | 7 |
| Other Non-Current Liabilities | 1 | 1 | 0 | 3 |
| Total Current Liabilities | 22 | 27 | 28 | 41 |
| Total Liabilities | 48 | 56 | 65 | 93 |
| Fixed Assets | 22 | 22 | 26 | 34 |
| Other Non-Current Assets | 3 | 3 | 3 | 3 |
| Total Current Assets | 23 | 31 | 36 | 56 |
| Total Assets | 48 | 56 | 65 | 93 |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 2 | 3 | 1 |
| Cash Flow from Operating Activities | 11 | 0 | 11 | 11 |
| Cash Flow from Investing Activities | -6 | -1 | -5 | -11 |
| Cash Flow from Financing Activities | -3 | 2 | -7 | 2 |
| Net Cash Inflow / Outflow | 2 | 1 | -1 | 2 |
| Closing Cash & Cash Equivalent | 2 | 3 | 1 | 3 |
| # | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|
| Earnings Per Share (Rs) | 4.45 | 1.62 | 7.21 | 9.53 |
| CEPS(Rs) | 5.68 | 2.92 | 8.54 | 11.57 |
| DPS(Rs) | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 13.87 | 15.49 | 22.97 | 32.49 |
| Core EBITDA Margin(%) | 18.07 | 9.82 | 17.08 | 16.84 |
| EBIT Margin(%) | 16.2 | 7.73 | 15.33 | 14.78 |
| Pre Tax Margin(%) | 12.38 | 5.23 | 13.81 | 13.57 |
| PAT Margin (%) | 9.45 | 3.52 | 10.24 | 10.15 |
| Cash Profit Margin (%) | 12.05 | 6.36 | 12.12 | 12.32 |
| ROA(%) | 11.97 | 4.04 | 15.51 | 15.63 |
| ROE(%) | 32.09 | 11.03 | 37.51 | 34.35 |
| ROCE(%) | 26.8 | 11.68 | 31.77 | 33.25 |
| Receivable days | 62.16 | 76.63 | 64.04 | 60.44 |
| Inventory Days | 46.05 | 55.88 | 47.7 | 55.37 |
| Payable days | 73.4 | 82.88 | 74.36 | 78.35 |
| PER(x) | 0 | 0 | 0 | 0 |
| Price/Book(x) | 0 | 0 | 0 | 0 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.32 | 0.37 | 0.19 | 0.16 |
| EV/Core EBITDA(x) | 1.72 | 3.45 | 1.12 | 0.94 |
| Net Sales Growth(%) | 0 | -2.43 | 53.21 | 33.28 |
| EBIT Growth(%) | 0 | -53.42 | 203.68 | 28.56 |
| PAT Growth(%) | 0 | -63.63 | 345.43 | 32.07 |
| EPS Growth(%) | 0 | -63.63 | 345.43 | 32.07 |
| Debt/Equity(x) | 1.05 | 1.09 | 0.55 | 0.48 |
| Current Ratio(x) | 1.04 | 1.15 | 1.32 | 1.37 |
| Quick Ratio(x) | 0.68 | 0.75 | 0.83 | 0.79 |
| Interest Cover(x) | 4.24 | 3.09 | 10.1 | 12.18 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0 |
| # | Sep 2023 | Mar 2024 |
|---|---|---|
| Promoter | 73.63 | 73.63 |
| FII | 3 | 0.03 |
| DII | 5.52 | 1.79 |
| Public | 17.85 | 24.55 |
| Others | 0 | 0 |
| Total | 100 | 100 |
| # | Sep 2023 | Mar 2024 |
|---|---|---|
| Promoter | 1.3 | 1.3 |
| FII | 0.05 | 0 |
| DII | 0.1 | 0.03 |
| Public | 0.32 | 0.43 |
| Others | 0 | 0 |
| Total | 1.77 | 1.77 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
You May Also Know About
